SHAREHOLDER ALERT: WeissLaw LLP Investigates CAI International, Inc.

NEW YORK, June 18, 2021 (GLOBE NEWSWIRE) --

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CAI International, Inc. (“CAI” or the “Company”) (NYSE: CAI) in connection with the proposed acquisition of the Company by Mitsubishi HC Capital Inc. The transaction is structured as an all-cash tender offer pursuant to which the Company’s shareholders will receive $56.00 for each share of CAI common stock that they own. The transaction is valued at approximately $2.9 billion.

If you own CAI shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website: 

Or please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771 

WeissLaw LLP is investigating whether (i) CAI’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the $56.00 offer price adequately compensates CAI’s shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.